4 doctors weighed in:

Are there any promising trials for new ulcerative colitis treatments?

4 doctors weighed in
Dr. Michael Fisher
Dermatology
3 doctors agree

In brief: Trials for colitis

An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

In brief: Trials for colitis

An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Dr. Michael Fisher
Dr. Michael Fisher
Thank
Dr. Michael Fisher
Dermatology
1 doctor agrees

In brief: Trials for colitis

An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

In brief: Trials for colitis

An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.
Dr. Michael Fisher
Dr. Michael Fisher
Thank
Get help from a real doctor now
Dr. Buck Parker
Board Certified, Surgery
13 years in practice
468K people helped
Continue
108,000 doctors available
Read more answers from doctors